Japanese healthcare company of Merck KGaA, the German science and technology group based in Darmstadt, with its office in Tokyo and known as Merck Serono until 2019 and as Merck Biopharma since. Markets the group's prescription medicines in Japan in oncology, neurology with multiple sclerosis treatments, fertility and endocrinology and cardiovascular and metabolic disease, and runs local clinical development, regulatory affairs, medical affairs and market access work with Japanese authorities and hospitals.
Aucun commentaire disponible.
Laissez votre note & commentaire